v3.26.1
Stock-Based Compensation (Tables)
6 Months Ended
Jun. 30, 2026
Equity [Abstract]  
Schedule of restricted stock units activity
               
    Number of
RSUs
    Weighted-average
grant-date
fair value
 
Unvested at Dec. 31, 2025     -       -  
Granted     225,000     $ 6.08  
Vested     (10,000 )   $ 6.21  
Forfeited     -       -  
Unvested at June 30, 2026     215,000     $ 6.08  
Schedule of weighted average assumptions
       
Assumption   April 29,
2026
grants
 
Market price of common stock   $ 3.36  
Exercise price   $ 3.36  
Expected term     6.0 years  
Expected volatility     120.0 %
Risk-free interest rate     3.75 %
Expected dividend yield     0.0 %
Weighted-average grant-date fair value   $ 2.94  
Schedule of stock option activity
                               
    Number of
options
    Weighted-average
exercise price
    Weighted-average
remaining
contractual term
    Aggregate
intrinsic value
 
Outstanding at Dec. 31, 2025     -       -       -       -  
Granted     1,600,000     $ 3.36       -       -  
Exercised     -       -       -       -  
Forfeited or expired     -       -       -       -  
Outstanding at June 30, 2026     1,600,000     $ 3.36       8.62 years       -  
Exercisable at June 30, 2026     200,000     $ 3.36       0.18 years       -  
Schedule of stock based compensation expense
               
    Three months ended
June
 30,
2026
    Six months ended
June
 30,
2026
 
Restricted stock unit compensation   $ 261,162     $ 261,162  
Stock-option compensation     272,061       272,061  
Total stock-based compensation expense   $ 533,223     $ 533,223  
Schedule of unrecognized compensation
       
Award type  

Unrecognized

cost

 
Stock options   $ 3,901,106  
RSUs     1,071,688  
Total   $ 4,972,794